These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25107849)

  • 1. Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia.
    Volk DW; Eggan SM; Horti AG; Wong DF; Lewis DA
    Schizophr Res; 2014 Oct; 159(1):124-9. PubMed ID: 25107849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.
    Eggan SM; Stoyak SR; Verrico CD; Lewis DA
    Neuropsychopharmacology; 2010 Sep; 35(10):2060-71. PubMed ID: 20555313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia.
    Eggan SM; Hashimoto T; Lewis DA
    Arch Gen Psychiatry; 2008 Jul; 65(7):772-84. PubMed ID: 18606950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia.
    Jenko KJ; Hirvonen J; Henter ID; Anderson KB; Zoghbi SS; Hyde TM; Deep-Soboslay A; Innis RB; Kleinman JE
    Schizophr Res; 2012 Nov; 141(2-3):185-8. PubMed ID: 22910406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex.
    Eggan SM; Mizoguchi Y; Stoyak SR; Lewis DA
    Cereb Cortex; 2010 May; 20(5):1164-74. PubMed ID: 19703937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia.
    Eggan SM; Lazarus MS; Stoyak SR; Volk DW; Glausier JR; Huang ZJ; Lewis DA
    Biol Psychiatry; 2012 Jan; 71(2):114-9. PubMed ID: 22036037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: a PET study.
    Takano A; Gulyás B; Varnäs K; Little PB; Noerregaard PK; Jensen NO; Elling CE; Halldin C
    Synapse; 2014 Mar; 68(3):89-97. PubMed ID: 24293119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia.
    Volk DW; Lewis DA
    Biol Psychiatry; 2016 Apr; 79(7):595-603. PubMed ID: 26210060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia.
    Gomes FV; Edelson JR; Volk DW; Grace AA
    Schizophr Res; 2018 Nov; 201():254-260. PubMed ID: 29705007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.
    Ranganathan M; Cortes-Briones J; Radhakrishnan R; Thurnauer H; Planeta B; Skosnik P; Gao H; Labaree D; Neumeister A; Pittman B; Surti T; Huang Y; Carson RE; D'Souza DC
    Biol Psychiatry; 2016 Jun; 79(12):997-1005. PubMed ID: 26432420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR.
    Wong DF; Kuwabara H; Horti AG; Raymont V; Brasic J; Guevara M; Ye W; Dannals RF; Ravert HT; Nandi A; Rahmim A; Ming JE; Grachev I; Roy C; Cascella N
    Neuroimage; 2010 Oct; 52(4):1505-13. PubMed ID: 20406692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study.
    Chou S; Fish KN; Lewis DA; Sweet RA
    Neurobiol Dis; 2023 Sep; 185():106262. PubMed ID: 37586566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex.
    Eggan SM; Melchitzky DS; Sesack SR; Fish KN; Lewis DA
    Neuroscience; 2010 Sep; 169(4):1651-61. PubMed ID: 20542094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral Symptoms in Premanifest Huntington Disease Correlate with Reduced Frontal CB
    Ceccarini J; Ahmad R; Van de Vliet L; Casteels C; Vandenbulcke M; Vandenberghe W; Van Laere K
    J Nucl Med; 2019 Jan; 60(1):115-121. PubMed ID: 29934407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laminar Distribution of Cannabinoid Receptor 1 in the Prefrontal Cortex of Nonhuman Primates.
    Han Y; Dong Q; Peng J; Li B; Sun C; Ma C
    Mol Neurobiol; 2024 Jul; 61(7):1-12. PubMed ID: 38062346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms.
    Raver SM; Keller A
    Neuropharmacology; 2014 Nov; 86():161-73. PubMed ID: 25036610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia.
    Zavitsanou K; Garrick T; Huang XF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):355-60. PubMed ID: 14751433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain.
    Perdikaris P; Tsarouchi M; Fanarioti E; Natsaridis E; Mitsacos A; Giompres P
    Neuropharmacology; 2018 Feb; 129():1-15. PubMed ID: 29113897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment.
    Urigüen L; García-Fuster MJ; Callado LF; Morentin B; La Harpe R; Casadó V; Lluis C; Franco R; García-Sevilla JA; Meana JJ
    Psychopharmacology (Berl); 2009 Oct; 206(2):313-24. PubMed ID: 19652957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study.
    Ceccarini J; Weltens N; Ly HG; Tack J; Van Oudenhove L; Van Laere K
    Transl Psychiatry; 2016 Jul; 6(7):e853. PubMed ID: 27404285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.